Toward Isozyme-Selective Inhibitors of Histone Deacetylase as Therapeutic Agents for the Treatment of Cancer

Pharmaceutical patent analyst - United Kingdom
doi 10.4155/ppa.12.21
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Future Science Ltd

Related search

Histone Deacetylase Inhibitors as Therapeutic Agents for Cancer Therapy: Drug Metabolism and Pharmacokinetic Properties

2011English

Histone Deacetylase Inhibitors as Cancer Therapeutics

Annals of Translational Medicine
Medicine
2016English

Discovery of Histone Deacetylase 8 Selective Inhibitors

Bioorganic and Medicinal Chemistry Letters
Organic ChemistryMolecular MedicineMolecular BiologyBiochemistryClinical BiochemistryPharmaceutical ScienceDrug Discovery
2011English

Combination Therapy With Histone Deacetylase Inhibitors (HDACi) for the Treatment of Cancer: Achieving the Full Therapeutic Potential of HDACi

Frontiers in Oncology
Cancer ResearchOncology
2018English

Histone Deacetylase Inhibitors in Cancer Therapy

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2009English

Inhibitors of Histone-Deacetylase

Journal of Applied Biomedicine
GeneticsMolecular BiologyPharmacologyBiochemistryBiological SciencesToxicologyMedicineAgriculturalNeurosciencePharmaceutics
2005English

Therapeutic Strategies to Enhance the Anticancer Efficacy of Histone Deacetylase Inhibitors

Journal of Biomedicine and Biotechnology
2011English

Preclinical Studies on Histone Deacetylase Inhibitors as Therapeutic Reagents for Endometrial and Ovarian Cancers

Future Oncology
MedicineCancer ResearchOncology
2011English

Thioredoxin in Cancer—Role of Histone Deacetylase Inhibitors

Seminars in Cancer Biology
Cancer Research
2006English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy